PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study comparing sequencing data from a cell culture model of OPMD and muscle tissue from OPMD patients suggested that shifts in alternative polyadenylation signal (PAS) usage correlated with loss of alternative isoforms of the PABPN1 transcript [42].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
Alternative polyadenylation of mRNA precursors
Tian, B., & Manley, J. L. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.116 · Cited by 1,179 · cited 2×
“7,8 Some are ubiquitously expressed and others have a cell-or tissue-specific expression.”
Translational Efficiency Is Regulated by the Length of the 3′ Untranslated Region
Tanguay, R. L., & Gallie, D. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.146 · Cited by 204
The role of alternative polyadenylation in the antiviral innate immune response
Jia, X., Yuan, S., Wang, Y., Fu, Y., Ge, Y., Ge, Y., Lan, X., Feng, Y., Qiu, F., Li, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14605 · Cited by 122
Research works printed but not linked: 42
- Ren, 2020, Alternative Polyadenylation: a new frontier in post transcriptional regulation, Biomark. Res., 8, 67, 10.1186/s40364-020-00249-6 · DOI
- Andreassi, 2009, To localize or not to localize: mRNA fate is in 3′UTR ends, Trends Cell Biol., 19, 465, 10.1016/j.tcb.2009.06.001 · DOI · Paper page
- de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res., 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
- Mitschka, 2022, Context-specific regulation and function of mRNA alternative polyadenylation, Nat. Rev. Mol. Cell Biol., 23, 779, 10.1038/s41580-022-00507-5 · DOI · Paper page
- Mei, 2022, Alternative Polyadenylation Utilization Results in Ribosome Assembly and mRNA Translation Deficiencies in a Model for Muscle Aging, J. Gerontol. A Biol. Sci. Med. Sci., 77, 1130, 10.1093/gerona/glac058 · DOI
- Gruber, 2019, Alternative cleavage and polyadenylation in health and disease, Nat. Rev. Genet., 20, 599, 10.1038/s41576-019-0145-z · DOI · Paper page
- Nishtala, 2016, Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks, Sci. Rep., 6, 10.1038/srep25711 · DOI
- Shulman, 2019, Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data, Nucleic Acids Res., 47, 10027, 10.1093/nar/gkz781 · DOI
- Chang, 2017, Alternative Polyadenylation in Human Diseases, Endocrinol. Metab., 32, 413, 10.3803/EnM.2017.32.4.413 · DOI
- Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
- Anvar, 2013, A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging, Aging (Albany NY), 5, 412, 10.18632/aging.100567 · DOI
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet., 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Tavanez, 2005, In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1, Rna, 11, 752, 10.1261/rna.7217105 · DOI
- Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum. Mol. Genet., 19, 2191, 10.1093/hmg/ddq098 · DOI
- Raz, 2011, Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein, Am. J. Pathol., 179, 1988, 10.1016/j.ajpath.2011.06.044 · DOI · Paper page
- de Leeuw, 2019, Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools, Eur. J. Hum. Genet., 27, 400, 10.1038/s41431-018-0302-4 · DOI
- Bagnoli, 2018, Sensitive and powerful single-cell RNA sequencing using mcSCRB-seq, Nat. Commun., 9, 2937, 10.1038/s41467-018-05347-6 · DOI · Paper page
- Datlinger, 2021, Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing, Nat. Methods, 18, 635, 10.1038/s41592-021-01153-z · DOI · Paper page
- Wilkins, 2021, Ultraplex: A rapid, flexible, all-in-one fastq demultiplexer, Wellcome Open Res., 6, 141, 10.12688/wellcomeopenres.16791.1 · DOI
- Mullan, 2021, ggVolcanoR: A Shiny app for customizable visualization of differential expression datasets, Comput. Struct. Biotechnol. J., 19, 5735, 10.1016/j.csbj.2021.10.020 · DOI
- Huang, 2007, DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists, Nucleic Acids Res., 35, W169, 10.1093/nar/gkm415 · DOI · Paper page
- Raz, 2014, A novel feed-forward loop between ARIH2 E3-ligase and PABPN1 regulates aging-associated muscle degeneration, Am. J. Pathol., 184, 1119, 10.1016/j.ajpath.2013.12.011 · DOI · Paper page
- Uhlén, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 10.1126/science.1260419 · DOI · Paper page
- Yuan, 2021, Alternative polyadenylation of mRNA and its role in cancer, Genes Dis., 8, 61, 10.1016/j.gendis.2019.10.011 · DOI
- Goering, 2021, LABRAT reveals association of alternative polyadenylation with transcript localization, RNA binding protein expression, transcription speed, and cancer survival, BMC Genom., 22, 476, 10.1186/s12864-021-07781-1 · DOI
- Chen, 2023, PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression, Cell Biosci., 13, 45, 10.1186/s13578-023-00997-6 · DOI
- Creemers, 2016, Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart, Circ. Res., 118, 433, 10.1161/CIRCRESAHA.115.307082 · DOI
- Cui, 2023, Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders, Nat. Commun., 14, 583, 10.1038/s41467-023-36311-8 · DOI
- Yoon, 2021, PAS-seq 2: A fast and sensitive method for global profiling of polyadenylated RNAs, Methods Enzymol., 655, 25, 10.1016/bs.mie.2021.03.013 · DOI
- Ye, 2018, APAtrap: identification and quantification of alternative polyadenylation sites from RNA-seq data, Bioinformatics, 34, 1841, 10.1093/bioinformatics/bty029 · DOI
- Ha, 2018, QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data, Genome Biol., 19, 45, 10.1186/s13059-018-1414-4 · DOI · Paper page
- Long, 2023, Accurate transcriptome-wide identification and quantification of alternative polyadenylation from RNA-seq data with APAIQ, Genome Res., 33, 644, 10.1101/gr.277177.122 · DOI
- Tang, 2022, Alternative polyadenylation by sequential activation of distal and proximal PolyA sites, Nat. Struct. Mol. Biol., 29, 21, 10.1038/s41594-021-00709-z · DOI
- Ichinose, 2014, Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer, Cancer Sci., 105, 1135, 10.1111/cas.12472 · DOI
- Riaz, 2016, PABPN1-Dependent mRNA Processing Induces Muscle Wasting, PLoS Genet., 12, 10.1371/journal.pgen.1006031 · DOI
- Olie, 2019, Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting, iScience, 12, 318, 10.1016/j.isci.2019.01.024 · DOI
- Roth, 2022, Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy, Acta Neuropathol., 144, 1157, 10.1007/s00401-022-02503-7 · DOI · Paper page
- Raz, 2014, Oculopharyngeal muscular dystrophy as a paradigm for muscle aging, Front. Aging Neurosci., 6, 317, 10.3389/fnagi.2014.00317 · DOI
- Banerjee, 2013, PABPN1: molecular function and muscle disease, FEBS J., 280, 4230, 10.1111/febs.12294 · DOI · Paper page
- Statello, 2021, Gene regulation by long non-coding RNAs and its biological functions, Nat. Rev. Mol. Cell Biol., 22, 96, 10.1038/s41580-020-00315-9 · DOI · Paper page
- Bergeron, 2015, Regulated Intron Retention and Nuclear Pre-mRNA Decay Contribute to PABPN1 Autoregulation, Mol. Cell Biol., 35, 2503, 10.1128/MCB.00070-15 · DOI
- Malerba, 2017, PABPN1 gene therapy for oculopharyngeal muscular dystrophy, Nat. Commun., 8, 10.1038/ncomms14848 · DOI · Paper page
Cited by
Ogut, E. (2025) · Clinics and Practice · doi:10.3390/clinpract15090169 · Cited by 107
Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Metadata
- Authors
- Shademan, M., Mei, H., van Engelen, B., Ariyurek, Y., Kloet, S., & Raz, V.
- ORCID
- Raz, Vered
- Venue
- Human Genetics and Genomics Advances
- Publisher
- Elsevier BV
- Published
- 2024-04
- Volume
- 5
- Issue
- 2
- Pages
- 100269
- ISSN
- 2666-2477
- Cited by
- 11
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Leiden University Medical Center
- Radboud Universitair Medisch Centrum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy. https://app.cochat.ai/papers/10.1016/j.xhgg.2024.100269
- The paper
- Shademan, M., Mei, H., van Engelen, B., Ariyurek, Y., Kloet, S., & Raz, V. (2024). PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy. Human Genetics and Genomics Advances. https://doi.org/10.1016/j.xhgg.2024.100269
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.